NCT03649139View on ClinicalTrials.gov

Effect and Underlying Immunological Mechanisms of Sublingual Immunotherapy in Allergic Rhinitis

PHASE3CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

October 30, 2018

Study Completion Date

October 30, 2018

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

sublingual immunotherapy drops

artemisia annua (sweet sagewort) allergen extract drops

DRUG

Placebo drops

sublingual placebo drops

Trial Locations (1)

100730

Beijing Tongren Hospital, Beijing

All Listed Sponsors
collaborator

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

UNKNOWN

lead

Beijing Tongren Hospital

OTHER

NCT03649139 - Effect and Underlying Immunological Mechanisms of Sublingual Immunotherapy in Allergic Rhinitis | Biotech Hunter | Biotech Hunter